Concord Biotech Limited Share Price & Analysis
₹1,209.9▼ -2.29%Updated 5 Jun 2026, 05:02 pm IST
LTP
₹1,209.9
-2.29%
Open
₹—
High
₹1,244.8
Low
₹1,196
Close
₹1,209.9
52W High
₹2,150
52W Low
₹987
Volume
208K
Lot Size
1
Sector
Healthcare
Market Cap
₹12K Cr
Face Value
₹1
Mid CapNIFTY 500
Price Chart
Fundamentals
P/E
46.4
Sector P/E
48.9
P/B
6.73
EPS
₹24.73
ROE
13.8%
ROCE
18.2%
D/E Ratio
0
Div Yield
0.92%
Book Value
₹193
+
Strengths
- ✓Efficient capital deployment (ROCE 18.2%)
- ✓Virtually debt-free
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,783 | ₹4.3L Cr | 34.4 | 5.12 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹6,616 | ₹1.7L Cr | 66.1 | 10.48 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,416 | ₹1.5L Cr | 66.4 | 17.81 | 27.6 | 15.4 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,315 | ₹1.2L Cr | 59.5 | 12.62 | 22.1 | 17.9 | 0.88 |
| CIPLA Cipla Limited | ₹1,402 | ₹1.1L Cr | 27.3 | 3.29 | 12.4 | 16.6 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,091 | ₹1.1L Cr | 20 | 4.05 | 21.2 | 21.2 | 0.38 |
| DRREDDY Dr. Reddy's Laboratories Limited | ₹1,283 | ₹1.1L Cr | 25.4 | 2.83 | 11.8 | 13.6 | 0.16 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
CONCORDBIO · as of Mar 2026
Promoters44.08%
FII9.10%▼0.25
DII8.85%▼0.31
Public37.94%▲0.53
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 44.08% | 44.08% | 44.08% | 44.08% | 44.08% | 44.08% |
| FII | 6.49% | 7.11% | 8.10% | 8.33% | 9.35% | 9.10% |
| DII | 8.41% | 10.35% | 9.89% | 9.65% | 9.16% | 8.85% |
| Public | 41.03% | 38.46% | 37.95% | 37.93% | 37.41% | 37.94% |
Corporate Events
Dividend - Rs 10.70 Per Share
Dividend2 Sept 2025
Annual General Meeting
AGM20 Jun 2024
Dividend - Rs 8.75 Per Share
Record: 21 Jun 2024
Dividend20 Jun 2024
About Concord Biotech Limited
Incorporated in 1984, Concord Biotech Limited is an India-based R&D-driven biopharma company and manufacturer of fermentation-based APIs across immunosuppressants and oncology.[1]
Healthcare · Pharmaceuticals & Biotechnology
Related Analysis
Frequently Asked Questions
What is Concord Biotech Limited share price today?▾
Concord Biotech Limited (CONCORDBIO) is currently trading at ₹1,209.9 on NSE, down 2.29% as of the last market session. Prices update daily after market close on MarketNetra.
Is Concord Biotech Limited available in F&O (Futures & Options)?▾
Yes, Concord Biotech Limited (CONCORDBIO) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Concord Biotech Limited 52-week high and low?▾
Concord Biotech Limited's 52-week high is ₹2,150 and the 52-week low is ₹987. The current price of ₹1,209.9 is 43.7% below the 52W high.
What is Concord Biotech Limited P/E ratio?▾
Concord Biotech Limited's current P/E ratio is 46.4. This indicates the market is paying ₹46.4 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Concord Biotech Limited options?▾
Concord Biotech Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade CONCORDBIO options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.